These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 223342

  • 1. [Catecholamines for treatment of severe heart failure (author's transl)].
    Mäurer W, Tillmanns H, Kübler W.
    Z Kardiol; 1979 May; 68(5):290-7. PubMed ID: 223342
    [Abstract] [Full Text] [Related]

  • 2. Use of catecholamines in acute myocardial infarction.
    Dixon DW, Loeb HS, Gunnar RM.
    Herz; 1979 Oct; 4(5):385-96. PubMed ID: 391685
    [Abstract] [Full Text] [Related]

  • 3. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M.
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [Abstract] [Full Text] [Related]

  • 4. [Haemodynamic effect of dobutamine in cardiac failure (author's transl)].
    Delius W, Wirtzfeld A, Sebening H, Mathes P.
    Dtsch Med Wochenschr; 1976 Nov 26; 101(48):1747-51. PubMed ID: 991768
    [Abstract] [Full Text] [Related]

  • 5. [Catecholamines in the therapy of chronic cardiac insufficiency].
    Brandt D, Klein W.
    Wien Med Wochenschr; 1982 Oct 15; 132(19):450-6. PubMed ID: 6294999
    [No Abstract] [Full Text] [Related]

  • 6. [Diagnostic possibilities and therapy in the acute phase of myocardial infarct].
    Pachinger O.
    Wien Med Wochenschr; 1984 Dec 31; 134(23-24):545-9. PubMed ID: 6442063
    [Abstract] [Full Text] [Related]

  • 7. [Combination of dopamine and dobutamine in the differential therapy of acute and chronic myocardial failure].
    Kleinschmidt R, Spannbrucker N, Vogel F.
    Dtsch Med Wochenschr; 1985 Apr 12; 110(15):598-603. PubMed ID: 2983969
    [No Abstract] [Full Text] [Related]

  • 8. [Dopamine and dobutamine in the treatment of severe cardiac failure (author's transl)].
    Wirtzfeld A, Klein G, Delius W, Himmler C, Volger E, Davidson J.
    Dtsch Med Wochenschr; 1978 Dec 01; 103(48):1915-21. PubMed ID: 710319
    [Abstract] [Full Text] [Related]

  • 9. The clinical use of inotropes in cardiac failure: dopamine, dobutamine, prenalterol and pirbuterol.
    Rae AP, Tweddel AC, Hutton I.
    Herz; 1983 Feb 01; 8(1):23-33. PubMed ID: 6832690
    [Abstract] [Full Text] [Related]

  • 10. [Catecholamines in internal medicine emergencies].
    Brandt D, Pristautz H, Klein W.
    Wien Med Wochenschr; 1984 Jul 31; 134(13-14):324-7. PubMed ID: 6495745
    [Abstract] [Full Text] [Related]

  • 11. [A comparison of cardiovascular effects of dobutamine and dopamine (author's transl)].
    Hess W, Brückner JB, Schmidt D, Schweichel E, Tarnow J.
    Z Kardiol; 1977 Oct 31; 66(10):537-44. PubMed ID: 919662
    [Abstract] [Full Text] [Related]

  • 12. [Catecholamine therapy in cardiogenic shock: helpful, useless or dangerous?].
    Schwertz H, Müller-Werdan U, Prondzinsky R, Werdan K, Buerke M.
    Dtsch Med Wochenschr; 2004 Sep 10; 129(37):1925-30. PubMed ID: 15372372
    [Abstract] [Full Text] [Related]

  • 13. Comparison of catecholamine effects on canine myocardial metabolism and regional blood flow during and after cardiopulmonary bypass.
    Ward HB, Einzig S, Wang T, Bianco RW, Foker JE.
    J Thorac Cardiovasc Surg; 1984 Mar 10; 87(3):452-65. PubMed ID: 6700252
    [Abstract] [Full Text] [Related]

  • 14. [Effect of nitroglycerine on haemodynamics and on catecholamine metabolism in patients with congestive left heart failure (author's transl)].
    Klein W, Brandt D, Fluch N, Maurer E.
    Acta Med Austriaca; 1980 Mar 10; 7(3):65-70. PubMed ID: 6784434
    [Abstract] [Full Text] [Related]

  • 15. Pharmacologic support in cardiogenic shock.
    Rude RE.
    Adv Shock Res; 1983 Mar 10; 10():35-49. PubMed ID: 6349299
    [Abstract] [Full Text] [Related]

  • 16. [Pharmacotherapy of severe heart failure with inodilators--new approaches].
    Baumann G, Hader O.
    Z Kardiol; 1996 Mar 10; 85 Suppl 4():9-19. PubMed ID: 9027110
    [Abstract] [Full Text] [Related]

  • 17. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R, Pucciarelli G, Nocerino L, Cocozza M, Setaro A, Torre G, Imperatore F.
    Minerva Cardioangiol; 1998 May 10; 46(5):163-74. PubMed ID: 9842199
    [Abstract] [Full Text] [Related]

  • 18. [Dobutamine: mechanisms of action and use in acute cardiovascular pathology].
    Vallet B, Dupuis B, Chopin C.
    Ann Cardiol Angeiol (Paris); 1991 Jun 10; 40(6):397-402. PubMed ID: 1859148
    [Abstract] [Full Text] [Related]

  • 19. The catecholamines: reappraisal of their use for acute myocardial infarction and the low cardiac output syndromes.
    Kones RJ.
    Crit Care Med; 1973 Jun 10; 1(4):203-20. PubMed ID: 4357984
    [No Abstract] [Full Text] [Related]

  • 20. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure.
    Erdmann E, Schwinger R, Böhm M.
    J Cardiovasc Pharmacol; 1990 Jun 10; 16 Suppl 5():S138-44. PubMed ID: 11527118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.